A Gut Microbe Could Hold a Key to Help People Benefit from Healthy Foods
Study reveals higher gut levels of Blastocystis in people who have better cardiometabolic health and a healthier diet.
Contact Information
Wang Building, 5th Floor
15 Parkman Street
Boston,
MA
02114
Phone: 617-726-5523
Fax: 617-724-5997
Email: mghpancreas@partners.org
Hours:
Monday–Friday, 8:00 am–5:00 pm
The Center for Interventional Endoscopy is an international leader in advanced endoscopic services for treating digestive disease. Our specialists are experts in minimally invasive endoscopic procedures including endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), tumor removal and enteral stenting. We use cutting-edge therapies to help our patients with digestive disease.
Our team treats the following digestive conditions:
Mass General is a leader in detecting early malignancies. We offer advanced endoscopic imaging techniques of the pancreas and biliary tract, including:
Mass General was one of the first U.S. hospitals to offer endoscopic retrograde cholangiopancreatography (ERCP), a minimally invasive procedure that combines X-ray and video endoscope technologies to diagnose and treat conditions of the bile ducts. We helped pioneer cholangioscopy, a new technique in ERCP, and have introduced other novel diagnostic and therapeutic approaches. Some of these approaches are available only at Mass General.
Other treatments include:Our diagnostic radiology team is composed of dedicated imaging specialists whose practice focuses specifically on GI scans (CT, MRI, PET). They are also nationally recognized for expertise in using the most sophisticated imaging tests to detect, diagnose and biopsy lesions in the pancreatic-biliary system.
Download our guide to What You Need to Know for Your Interventional Endoscopy Procedure (PDF, 160KB).
Our expert team uses many cutting-edge developmental technologies to treat and diagnose digestive disease. This includes support for NIH-funded investigations on EUS-targeted stem cell therapy for liver disease and motility disorders.
We are proud of the many trainees we’ve taught and mentored over the years. We continue to teach residents, fellows and peers. Our providers organize and participate in myriad national and international courses to train practicing gastroenterologists and other specialists. We developed one of the first video atlases used globally to share endoscopic innovations. Our team has served on numerous panels to develop guidelines and standards of practice relating to gastrointestinal care and how to measure and improve the quality of endoscopic procedures.
We are pleased to announce that U.S. News & World Report has ranked us among the top in the country in adult gastroenterology and GI surgery.
Study reveals higher gut levels of Blastocystis in people who have better cardiometabolic health and a healthier diet.
Hanseul Kim, PhD, is the lead author of a recently published research letter in the journal Gastroenterology, Altered Microbial Transcription in Long-Term Proton Pump Inhibitor Usage: Findings From a US Cohort Study
Results warrant additional studies into the health benefits of aspirin for patients with metabolic dysfunction–associated steatotic liver disease.
Andrew Chan, MD, MPH is co-leading the global team known as PROSPECT, which received a grant of up to $25m over five years, to study early-onset colorectal cancer from Cancer Grand Challenges after an international competition.
In a nationally representative of US adults with self-reported chronic liver disease (CLD), approximately 308,000 (6%) identified delaying medical care due to transportation barriers.
Michael Dougan, MD, PhD, is a senior author of a new study in Clinical Gastroenterology and Hepatology, Tofacitinib Is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis.
Call the Center for Interventional Endoscopy or use our online forms to request an appointment or refer a patient.